Free Trial

Promising Dividend Stocks To Watch Today - November 6th

ProShares UltraPro Short QQQ logo with background
Image from MarketBeat Media, LLC.

Key Points

  • MarketBeat’s screener named ProShares UltraPro Short QQQ (SQQQ), Pfizer, and Chevron as dividend stocks to watch, based on their high recent dollar trading volume.
  • SQQQ seeks daily returns equal to three times the inverse of the Nasdaq-100’s daily performance. Its shares fell $2.58 to $46.97 on Friday, with volume above its average.
  • On Friday, Pfizer shares fell $0.52 to $29.36, while Chevron rose $0.30 to $213.23.
  • MarketBeat previews top five stocks to own in December.

ProShares UltraPro Short QQQ, Pfizer, and Chevron are the three Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend stocks are shares of companies that regularly pay part of their profits or cash flow to shareholders, typically as cash payments called dividends. Investors may value them for income, but dividends can be reduced or stopped, and a stock’s overall return also depends on changes in its share price. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

Shares of SQQQ stock traded down $2.58 during trading hours on Friday, reaching $46.97. The company had a trading volume of 66,327,556 shares, compared to its average volume of 55,972,980. The company has a 50 day moving average of $37.33 and a 200 day moving average of $49.82. ProShares UltraPro Short QQQ has a 1-year low of $31.42 and a 1-year high of $90.71.

Read Our Latest Research Report on SQQQ

Pfizer (PFE)

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.

Shares of Pfizer stock traded down $0.52 during trading on Friday, reaching $29.36. 28,240,868 shares of the company were exchanged, compared to its average volume of 39,838,250. The business has a 50-day moving average price of $28.72 and a 200-day moving average price of $26.88. The firm has a market capitalization of $167.33 billion, a price-to-earnings ratio of 41.91, a P/E/G ratio of 2.04 and a beta of 0.31. The company has a quick ratio of 0.96, a current ratio of 1.42 and a debt-to-equity ratio of 0.67. Pfizer has a twelve month low of $23.62 and a twelve month high of $31.44.

Read Our Latest Research Report on PFE

Chevron (CVX)

Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant.

Shares of Chevron stock traded up $0.30 during trading on Friday, hitting $213.23. 3,768,122 shares of the company were exchanged, compared to its average volume of 10,249,335. The firm has a market capitalization of $421.29 billion, a P/E ratio of 15.60, a price-to-earnings-growth ratio of 0.51 and a beta of 0.47. The firm's fifty day moving average price is $214.66 and its 200 day moving average price is $194.17. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.25 and a quick ratio of 0.98. Chevron has a 1-year low of $146.49 and a 1-year high of $236.48.

Read Our Latest Research Report on CVX

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in ProShares UltraPro Short QQQ Right Now?

Before you consider ProShares UltraPro Short QQQ, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProShares UltraPro Short QQQ wasn't on the list.

While ProShares UltraPro Short QQQ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines